Home 5 Articles 5 FDA Issues First Approval for SARS-CoV-2 Breathalyzer Test

FDA Issues First Approval for SARS-CoV-2 Breathalyzer Test

by | May 2, 2022

InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.

InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.

This content is Exclusive to Lab Industry Report Subscribers

Subscribe or Log in for Exclusive Access.